HTGF exits KonTEM in trade sale

After initial research was conducted at the Max Planck Institute for Biophysics in Frankfurt, further development turned it into a marketable product, which is currently in the customer test period. Its new owner, FEI, is a global operator in the field of high-performance microscopy workflow solutions.

Previous funding
HTGF has divested its stake in the Max Planck Society spinout after a two-year holding period, having initially invested in April 2012. The fund recently sold its stake in LED Exchange to private investors, after initially backing the lighting specialist in late 2012.

Company
Founded in April 2010 by Patrick Kurth and Stefen Pattai, KonTEM is based in Bonn. It provides a phase contrast system for transmission electron microscopy (TEM), which KonTEM claims gives a two to three times better image contrast without compromising resolution. Currently, nine people are employed by KonTEM.

KonTEM is a spinout from The Caesar Foundation – a centre for neuroscientific research in Bonn – and Munich-based Max Planck Innovation. The company serves as a link between industry and the research and technology of the Max Planck Society.

People
Andreas Olmes is investment director at HTGF. Joerg Wamser is managing director at KonTEM.

Advisers
Equity - Weitnauer (Legal).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• DACH
• Healthcare
• Exits
• Germany
• High-Tech Gründerfonds
• Trade sale